Meridian Bioscience (VIVO) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Piper Jaffray Upgrades Meridian Biosciences (VIVO) to Neutral
May 1, 2019 2:36 AM EDTPiper Jaffray analyst William Quirk upgraded Meridian Biosciences (NASDAQ: VIVO) from Underweight to Neutral with a price target of $11.00 (from $15.00).
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $11.51 yesterday.
... More